OCCUPATIONAL BRONCHIAL ASTHMA: ETIOLOGICAL FACTORS, DIAGNOSIS, TREATMENT


Citar

Texto integral

Resumo

The article is dedicated to the problem of occupational bronchial asthma (OBA) - a chronic respiratory disease caused by agents acting on the respiratory tract in the workplace. Classification and the main etiological factors of OBA, pathogenesis, clinical symptoms, and diagnostic criteria for the disease are presented. Particular attention is paid to the stepwise therapy of asthma, which takes into account the etiologic factor, data of the immunological examination and the individual patients characteristics; prevention and medical and social assessment of the OBA are discussed.

Bibliografia

  1. Артамонова В.Г., Мухин Н.А. Профессиональные болезни. М., 2004. 432 с.
  2. Косарев В.В., Бабанов С.А. Профессиональные болезни. М., 2010. 368 с.
  3. Профессиональная патология. Национальное руководство / Под ред. Н.Ф. Измерова. М., 2011. 784 с.
  4. Саакадзе В.П., Степанов С.А. Профессиональная бронхиальная астма. Саратов, 1989. С. 17-41.
  5. GINA Report, Global Strategy for Asthma Management and Prevention. Published November 2011. http://www.ginasthma.org.
  6. Степанов С.А. К вопросу о природе так называемой "зерновой лихорадки" // Казанский мед. журнал 1968. № 8. С. 8-13.
  7. Макова Е.В. Клинические и иммунологические аспекты профессиональной аллергии к натуральному латексу. Дисс. канд. мед. наук. Самара, 2003.
  8. Клинические рекомендации. Бронхиальная астма / Под ред. А.Г. Чучалина. М., 2008. 224 с.
  9. Косарев В.В., Бабанов С.А. Профессиональные заболевания медицинских работников. Самара, 2009. 232 с.
  10. Tilles SA, Jerath-Tatum A. Differential diagnosis of occupational asthma. Immunol Allergy Clin N Am 2003;23:167-76.
  11. Sastre J, Vandesplas O, Park HS. Pathogenesis of occupational asthma. Eur Respir J 2003;22:364-67.
  12. Wan H, Winton HL, Soeller C, et al. Der p1 facilitates transepithelial allergen delivery by disruption of tight functions. J Clin Invest 1999;104:123-33.
  13. Agius RM, Nee J, Mc Govern B, Robertson A. Structure activity hypotheses in occupational asthma caused by low molecular weight substances. Ann Occup Hyg 1991;35:129-21.
  14. Maestrelli P, Saetta M, Mapp C, Fabri LM. Mechanisms of occupational asthma. Clin Exp Allergy 1997;27(1):47-54.
  15. Maestrelli P, del Prete GF, De Carli M, et al. CD8 T-cell clones producing interleukin-5 and interferongamma in bronchial mucosa of patients with asthma induced by toluene diisocyanate. Scand J Work Environ Hlth 1994;20:376-81.
  16. Saetta M, Di Stefano A, Maestrelli P, et al. Airway mucos al inflammation in occupational asthma induced by toluene diisocyanate. Am Rev Respir Dis 1992;145:160-68.
  17. Frew AJ, Chan H, Lam S, Chan-Yeung M. Bronchial inflammation in asthma due to western red cedar. Am J Respir Crit Care Med 1995;151:340-44.
  18. Косарев В.В., Бабанов С.А. Справочник врача-пульмонолога. Ростов-на-Дону, 2011. 446 с.
  19. Петровская Е.В. Клинико-иммунологические особенности профессиональной бронхиальной астмы. Дисс. канд. мед. наук. Самара, 2009.
  20. Rabe KF, Atienza T, Magyar P, et al. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 2006;368(9537):744-53.
  21. Vogelmeier C, D'Urzo A, Pauwels R, et al. Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur Respir J 2005;26(5):819-28.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2012

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies